What Iq Biosciences does

Iq Biosciences is a privately held contract research organization founded in 2013 and headquartered in Berkeley, California. The company provides research testing, drug discovery, and diagnostic services, serving three distinct client segments: pharmaceutical companies, biotechnology firms, and academic institutions. Its offering sits at the intersection of fee-for-service lab work and translational research support, positioning it as a small, specialized outsourced research partner rather than a vertically integrated therapeutics developer.

The firm's headcount of 11–50 employees and single disclosed executive (CEO Chris Ng) indicate a compact operating footprint typical of niche CROs that compete on scientific expertise, turnaround time, and customization rather than scale. Detailed information on service menus, assay menus, instrument platforms, pricing models, contract structures, or proprietary technology is not publicly available — the company's website presents a verification/loading screen with no substantive product or pricing detail, and no patents, certifications, or third-party accreditations are documented in the source data.

The business model appears to be project- or contract-based fee-for-service billing common to small CROs, with revenue derived from per-assay or per-study engagements across the three stated customer segments. There are no disclosed funding rounds, no M&A activity, no published customer logos, no distribution or marketing channels, and no operating geography beyond the Berkeley, CA base. As a result, while the company's service category and customer scope are well-defined, the inputs needed to assess its competitive intensity, win rates, backlog, or growth dynamics are not available.

Name

Iq Biosciences

Website

https://iqbiosciences.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Iq Biosciences is a privately held Berkeley-based contract research organization that provides research testing, drug discovery, and diagnostic services to pharmaceutical, biotechnology, and academic clients. Founded in 2013, it operates with 11–50 employees under CEO Chris Ng.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Testing Laboratories and Services (541380)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Research testing services
• Drug discovery services
• Diagnostic services
• Biopharmaceutical research
• Academic research support

Headquarters

HQ city

Berkeley

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Core offering

Iq Biosciences provides research testing, drug discovery, and diagnostic services for pharmaceutical, biotechnology, and academic sectors. The company supports scientific research and development through laboratory-based services based in Berkeley, United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Testing Services
• Drug Discovery Services
• Diagnostic Services

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights1 record

Direct peers

• Reaction Biology: Mid-sized CRO focused on discovery biochemistry, biophysics, and screening services for pharma and biotech. Closely comparable in drug discovery and research testing offerings.
• Quintara Discovery: Specialty CRO providing in vitro pharmacology, ADME, and bioanalytical services to pharma and biotech. Direct peer in research testing and drug discovery services.
• Bionova Scientific: Bay Area-based biologics CDMO/CRO serving biotech and pharma with process development and analytical services. Local direct peer in research testing and drug development services.
• Aragen Life Sciences: Contract research organization offering discovery, development, and manufacturing services across small molecules and biologics. Direct peer in research testing and drug discovery offerings.

Broad incumbents

• IQVIA: Global life sciences services firm combining clinical research, laboratory, and data capabilities. Broad incumbent comparable across pharma and biotech service categories.
• Charles River Laboratories: Global CRO offering discovery, safety assessment, and laboratory services to pharma and biotech. A much larger incumbent in the same research testing and drug discovery services space Iq Biosciences operates in.
• Eurofins Scientific: International life science testing services group with deep pharma and academic diagnostics offerings. Broad incumbent competitor across research testing and diagnostic service categories.
• Labcorp (Fortrea spin): Major clinical diagnostics and drug development services provider serving pharma, biotech, and academic sectors. Direct overlap in diagnostic services and lab-based research testing for life sciences clients.
• WuXi AppTec: Large CRO/CDMO offering discovery, preclinical, and laboratory services to global pharma and biotech. Incumbent with overlapping drug discovery and research testing offerings.

Regional players

• Bio-Rad Laboratories: Hercules/Bay Area life science tools and clinical diagnostics company serving pharma, biotech, and academic labs. Regional peer with overlapping diagnostics and lab research testing exposure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iq Biosciences